Novartis AG
Xetra: NOT
▲
79.60
+0.18
+0.23%
1 Day
-
Open
79.58
-
Previous Close
79.42
-
Volume (Avg)
15.72k (13.56k)
-
Day's Range
78.98-79.64
-
52Wk Range
62.14-81.84
-
Market Cap.
183.97B
-
Dividend Rate (Yield)
2.70 (3.17%)
-
Beta
0.71
-
Shares Outstanding
2.31B
-
P/E Ratio (EPS)
16.67 (5.38)
Top Stories
-
Drug Delivery Devices Market Comprehensive Study by Key Players 2019-2026: Johnson & Johnson, Phillips, Novartis AG, 3M, Catalent
Digital Journal 5 hrs agoNew York, NY -- (SBWIRE) -- 02/18/2019 -- A new market assessment report on the Drug Delivery Devices market provides a comprehensive overview of the Drug Delivery Devices industry for the forecast period 2019 - 2026. The analytical study is proposed to ...
-
Novartis Positioned to Be World's Top Drug Seller in 2024
Yahoo Finance -
Surgical Microscopes Market Growth by Top Key Players - Carl Zeiss, Novartis AG, Leica Microsystems
openpr.com -
Novartis AG (NVS) Holdings Reduced by Whittier Trust Co.
dispatchtribunal.com -
Keloid Treatment Market Set for Rapid Growth During by 2024
MarketWatch 14 hrs agoBristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals International Inc., Galena Biopharma, Inc., RXi Pharmaceuticals, Inc., and Avita Medical. Global Keloid Treatment Market is segmented based on the treatments type as ...
-
Smart Pills Technology Market Latest Trends, Technology Advancement and Demands 2019 to 2023
Digital Journal -
Colorectal Cancer Recent Therapeutic Developments, Market Size, Share and Professional Synthesis Report 2019, Forecast to 2023
MarketWatch -
Novartis AG (NVS) Shares Bought by Bellecapital International Ltd.
dispatchtribunal.com -
Stroke Disorder and Treatment Market 2019 Key Country Analysis: AstraZeneca, Pfizer, Bayer Pharma AG, Daiichi Sankyo, Novartis AG and other
openpr.com
